Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesia Approaches for Rib Fractures
NCT06519929Phase 4Active, not recruiting
- Sponsor
- Thomas Jefferson University
- Start
- Sep 2024
- Primary completion
- Aug 2025
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection, Lidocaine Hydrochloride Injection, without epinephrine in rib fracture, sponsored by Thomas Jefferson University. Started Sep 2024; status: active, not recruiting.
02
Drugs
ropivacaine hydrochloride liposomal suspension injectionLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
rib fracture
Beyond the preview
Go deeper on NCT06519929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06519929.